The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 12, 2019

Filed:

May. 13, 2015
Applicant:

Ariad Pharmaceuticals, Inc., Cambridge, MA (US);

Inventors:

Wei-Sheng Huang, Acton, MA (US);

Yongjin Gong, Belmont, MA (US);

Feng Li, Winchester, MA (US);

Nicholas E. Bencivenga, Malden, MA (US);

David C. Dalgarno, Brookline, MA (US);

Anna Kohlmann, Winchester, MA (US);

William C. Shakespeare, Southborough, MA (US);

Ranny M. Thomas, Sharon, MA (US);

Xiaotian Zhu, Newton, MA (US);

Angela West, Franklin, MA (US);

Willmen Youngsaye, Boston, MA (US);

Yun Zhang, Acton, MA (US);

Tianjun Zhou, Belmont, MA (US);

Assignee:

ARIAD PHARMACEUTICALS, INC., Cambridge, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/14 (2006.01); A61K 31/506 (2006.01); C07D 471/04 (2006.01); C07D 405/12 (2006.01); C07D 403/04 (2006.01); C07D 401/14 (2006.01); C07F 9/6558 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 405/12 (2013.01); C07F 9/65583 (2013.01);
Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.


Find Patent Forward Citations

Loading…